Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cerilliant
Daiichi Sankyo
Dow
Express Scripts
Johnson and Johnson
Farmers Insurance
Chubb
Boehringer Ingelheim

Generated: April 21, 2018

DrugPatentWatch Database Preview

CEFTAZIDIME IN DEXTROSE CONTAINER Drug Profile

« Back to Dashboard

When do Ceftazidime In Dextrose Container patents expire, and when can generic versions of Ceftazidime In Dextrose Container launch?

Ceftazidime In Dextrose Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Summary for CEFTAZIDIME IN DEXTROSE CONTAINER
Drug patent expirations by year for CEFTAZIDIME IN DEXTROSE CONTAINER
Pharmacology for CEFTAZIDIME IN DEXTROSE CONTAINER
Medical Subject Heading (MeSH) Categories for CEFTAZIDIME IN DEXTROSE CONTAINER

US Patents and Regulatory Information for CEFTAZIDIME IN DEXTROSE CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFTAZIDIME IN DEXTROSE CONTAINER ceftazidime INJECTABLE;INJECTION 050823-001 Jun 13, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
B Braun CEFTAZIDIME IN DEXTROSE CONTAINER ceftazidime INJECTABLE;INJECTION 050823-002 Jun 13, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Citi
Cerilliant
AstraZeneca
Accenture
Moodys
Boehringer Ingelheim
McKesson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.